Int Fertility Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.95 Cr
as on 16-11-2024
- Satisfied Charges ₹ 6.50 M
as on 16-11-2024
- Revenue 18.41%
(FY 2023)
- Profit 23.78%
(FY 2023)
- Ebitda 40.63%
(FY 2023)
- Net Worth 39.18%
(FY 2023)
- Total Assets -13.70%
(FY 2023)
About Int Fertility Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.95 Cr. The company has closed loans amounting to ₹6.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shashi and Sanjay Singh serve as directors at the Company.
- CIN/LLPIN
U85100DL2018PTC332890
- Company No.
332890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Int Fertility Centre?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shashi | Director | 29-Apr-2023 | Current |
Sanjay Singh | Director | 30-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Int Fertility Centre.
Int Fertility Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.41% increase. The company also saw a substantial improvement in profitability, with a 23.78% increase in profit. The company's net worth Soared by an impressive increase of 39.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Int Fertility Centre?
In 2023, Int Fertility Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 12 Sep 2024 | ₹9.95 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Mar 2024 | ₹5.00 M | Satisfied |
Hdfc Bank Limited Creation Date: 28 Sep 2019 | ₹1.50 M | Satisfied |
How Many Employees Work at Int Fertility Centre?
Int Fertility Centre has a workforce of 1 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Int Fertility Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Int Fertility Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.